血液恶性肿瘤相关嗜酸性皮病皮肤中辅助性T细胞2型相关分子过表达
该研究通过免疫组化、免疫荧光和ELISA比较了12例EDHM、11例大疱性类天疱疮(BP)和5例健康对照(HC)的皮肤及血清样本,发现EDHM皮肤中T细胞标志物、Th2相关分子(GATA3、IL-4、IL-31)及Eotaxin-1显著过表达,血清IL-4水平升高,提示靶向Th2相关分子尤其是IL-4可能对EDHM治疗有益。
要点
- EDHM皮肤中CD4+ T细胞和Th2标志物GATA3占优势。
- IL-4和IL-31在EDHM皮肤中过表达并与GATA3共定位。
- Eotaxin-1在EDHM中较BP和HC显著过表达。
核心结论
- 靶向Th2相关分子尤其是IL-4可能对EDHM的治疗有前景。
研究设计与样本
- 免疫组化和免疫荧光分析12例EDHM、11例BP和5例HC的皮肤样本。
- ELISA检测11例EDHM、11例BP和5例HC的血清IL-4水平。
主要发现
- EDHM和BP皮肤中CD3、CD4、CD8、CD5显著过表达于HC。
- EDHM皮肤中CD4+细胞多于CD8+细胞,GATA3+细胞多于T-bet+细胞。
- FOXP3表达增加但FOXP3/CD4比值低。
- B细胞标志物表达不足,三组间无显著差异。
- IL-4和IL-31在EDHM和BP中显著过表达于HC,并与GATA3共定位。
临床怎么用
- 对EDHM患者可考虑评估Th2相关炎症通路。
- 靶向IL-4可能作为EDHM的潜在治疗策略。
局限性
- 样本量小。
- 回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Eosinophilic dermatosis of hematologic malignancy (EDHM) is a rare dermatosis associated with blood tumors. OBJECTIVE: To characterize the expression of T-cell and B-cell markers and pruritogenic mediators in EDHM skin. METHODS: Immunohistochemical and immunofluorescence analysis were performed in 12 skin samples of EDHM, 11 samples of bullous pemphigoid (BP), and 5 samples from healthy controls (HC). Serum levels of interleukin (IL) 4 were analyzed in 11 patients with EDHM, 11 BP patients, and 5 HC by enzyme-linked immunosorbent assay. RESULTS: T-cell markers, including clusters of differentiation (CD) 3, CD4, CD8, and CD5 were significantly overexpressed in EDHM and BP skin compared to HC. A predominance of CD4+ over CD8+ cells and GATA3+ (helper T cell type 2 [Th2] marker) over T-bet+ (Th1 marker) cells were observed. FOXP3 expression was increased but the FOXP3/CD4 ratio was low. B-cell markers were under-represented, without significant differences between the 3 groups. IL-4 and IL-31 were significantly overexpressed in EDHM and BP compared to HC and colocalized with the Th2-associated marker GATA3. Eotaxin-1 was significantly overexpressed in EDHM compared to BP and HC. IL-4 serum concentration was significantly increased in EDHM and BP compared to HC. LIMITATIONS: Small sample size; retrospective design. CONCLUSIONS: Targeting Th2-related molecules, in particular IL-4, holds promise for EDHM management.
引用
- Maglie R, Ugolini F, De Logu F, et al. Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy. J Am Acad Dermatol. 2021. PMID: 34265409. doi:10.1016/j.jaad.2021.07.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。